Pennar Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 10, 2025, 9:55 pm

Competitors of Pennar Industries Ltd

All Competitor Stocks of Pennar Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:35 am

Below is a detailed analysis of the quarterly data for Pennar Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 846.00 Cr.. The value appears to be declining and may need further review. It has decreased from 906.00 Cr. (Mar 2025) to 846.00 Cr., marking a decrease of 60.00 Cr..
• For Expenses, as of Jun 2025, the value is 760.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 815.00 Cr. (Mar 2025) to 760.00 Cr., marking a decrease of 55.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00%.
• For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 7.00 Cr..
• For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Mar 2025) to 20.00%, marking a decrease of 4.00%.
• For Net Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 32.00 Cr., marking a decrease of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.37. The value appears to be declining and may need further review. It has decreased from 2.64 (Mar 2025) to 2.37, marking a decrease of 0.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:18 pm

Growth

Last Updated: September 5, 2025, 12:10 pm

Balance Sheet

Last Updated: December 4, 2025, 1:47 am

Below is a detailed analysis of the balance sheet data for Pennar Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 67.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,002.00 Cr.. The value appears strong and on an upward trend. It has increased from 931.00 Cr. (Mar 2025) to 1,002.00 Cr., marking an increase of 71.00 Cr..
• For Borrowings, as of Sep 2025, the value is 993.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 812.00 Cr. (Mar 2025) to 993.00 Cr., marking an increase of 181.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,268.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,143.00 Cr. (Mar 2025) to 1,268.00 Cr., marking an increase of 125.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 3,331.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,953.00 Cr. (Mar 2025) to 3,331.00 Cr., marking an increase of 378.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,046.00 Cr.. The value appears strong and on an upward trend. It has increased from 947.00 Cr. (Mar 2025) to 1,046.00 Cr., marking an increase of 99.00 Cr..
• For CWIP, as of Sep 2025, the value is 125.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2025) to 125.00 Cr., marking an increase of 72.00 Cr..
• For Investments, as of Sep 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 3.00 Cr..
• For Other Assets, as of Sep 2025, the value is 2,145.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,941.00 Cr. (Mar 2025) to 2,145.00 Cr., marking an increase of 204.00 Cr..
• For Total Assets, as of Sep 2025, the value is 3,331.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,953.00 Cr. (Mar 2025) to 3,331.00 Cr., marking an increase of 378.00 Cr..

Notably, the Reserves (1,002.00 Cr.) exceed the Borrowings (993.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Pennar Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.84. This value is within the healthy range. It has increased from 7.29 (Mar 24) to 8.84, marking an increase of 1.55.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.84. This value is within the healthy range. It has increased from 7.29 (Mar 24) to 8.84, marking an increase of 1.55.
• For Cash EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 12.22 (Mar 24) to 14.00, marking an increase of 1.78.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.99. It has increased from 64.95 (Mar 24) to 73.99, marking an increase of 9.04.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.99. It has increased from 64.95 (Mar 24) to 73.99, marking an increase of 9.04.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 239.11. It has increased from 232.00 (Mar 24) to 239.11, marking an increase of 7.11.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 25.75. This value is within the healthy range. It has increased from 23.22 (Mar 24) to 25.75, marking an increase of 2.53.
• For PBIT / Share (Rs.), as of Mar 25, the value is 20.64. This value is within the healthy range. It has increased from 18.29 (Mar 24) to 20.64, marking an increase of 2.35.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.78. This value is within the healthy range. It has increased from 9.74 (Mar 24) to 11.78, marking an increase of 2.04.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.89. This value is within the healthy range. It has increased from 7.29 (Mar 24) to 8.89, marking an increase of 1.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.84. This value is within the healthy range. It has increased from 7.29 (Mar 24) to 8.84, marking an increase of 1.55.
• For PBDIT Margin (%), as of Mar 25, the value is 10.76. This value is within the healthy range. It has increased from 10.00 (Mar 24) to 10.76, marking an increase of 0.76.
• For PBIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 7.88 (Mar 24) to 8.63, marking an increase of 0.75.
• For PBT Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 10. It has increased from 4.19 (Mar 24) to 4.92, marking an increase of 0.73.
• For Net Profit Margin (%), as of Mar 25, the value is 3.71. This value is below the healthy minimum of 5. It has increased from 3.14 (Mar 24) to 3.71, marking an increase of 0.57.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.69. This value is below the healthy minimum of 8. It has increased from 3.14 (Mar 24) to 3.69, marking an increase of 0.55.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.94. This value is below the healthy minimum of 15. It has increased from 11.21 (Mar 24) to 11.94, marking an increase of 0.73.
• For Return on Capital Employeed (%), as of Mar 25, the value is 21.82. This value is within the healthy range. It has decreased from 23.11 (Mar 24) to 21.82, marking a decrease of 1.29.
• For Return On Assets (%), as of Mar 25, the value is 4.03. This value is below the healthy minimum of 5. It has increased from 3.72 (Mar 24) to 4.03, marking an increase of 0.31.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has increased from 0.15 (Mar 24) to 0.20, marking an increase of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.77. This value is within the healthy range. It has decreased from 0.83 (Mar 24) to 0.77, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.15. It has decreased from 1.26 (Mar 24) to 1.15, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 1.5. It has increased from 1.04 (Mar 24) to 1.14, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 24) to 0.57, marking an increase of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 4. It has decreased from 2.42 (Mar 24) to 2.21, marking a decrease of 0.21.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 3. It has increased from 2.72 (Mar 24) to 2.90, marking an increase of 0.18.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.00. This value is below the healthy minimum of 3. It has increased from 1.85 (Mar 24) to 2.00, marking an increase of 0.15.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,118.88. It has increased from 2,389.31 (Mar 24) to 3,118.88, marking an increase of 729.57.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.76 (Mar 24) to 0.96, marking an increase of 0.20.
• For EV / EBITDA (X), as of Mar 25, the value is 8.98. This value is within the healthy range. It has increased from 7.63 (Mar 24) to 8.98, marking an increase of 1.35.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.78, marking an increase of 0.21.
• For Price / BV (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has increased from 2.05 (Mar 24) to 2.54, marking an increase of 0.49.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.78, marking an increase of 0.21.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.04, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness